122 related articles for article (PubMed ID: 3141498)
1. In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.
Cleveland MG; Annable CR; Klimpel GR
J Immunol; 1988 Nov; 141(10):3349-56. PubMed ID: 3141498
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production.
Klimpel GR; Annable CR; Cleveland MG; Jerrells TR; Patterson JC
J Immunol; 1990 Jan; 144(1):84-93. PubMed ID: 2104894
[TBL] [Abstract][Full Text] [Related]
3. IFN-beta production by macrophages obtained from mice undergoing graft vs host disease.
Cleveland MG; Ramirez RB; Klimpel GR
J Immunol; 1988 Dec; 141(11):3823-7. PubMed ID: 2846694
[TBL] [Abstract][Full Text] [Related]
4. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice.
Stark J; Weiss L; Slavin S
Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887
[TBL] [Abstract][Full Text] [Related]
6. T cell regulation of interferon-alpha/beta (IFN-alpha/beta) production by alloantigen-stimulated bone marrow cells.
Reyes VE; Klimpel KD; Klimpel GR
J Immunol; 1985 May; 134(5):3137-41. PubMed ID: 2858508
[TBL] [Abstract][Full Text] [Related]
7. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
9. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
[TBL] [Abstract][Full Text] [Related]
10. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
Maier T; Holda JH
J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
[TBL] [Abstract][Full Text] [Related]
11. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
Maier T; Holda JH; Claman HN
J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
[TBL] [Abstract][Full Text] [Related]
12. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
Ellison CA; Fischer JM; HayGlass KT; Gartner JG
J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
[TBL] [Abstract][Full Text] [Related]
13. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
[TBL] [Abstract][Full Text] [Related]
14. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
15. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
Rus V; Svetic A; Nguyen P; Gause WC; Via CS
J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
Brok HP; Vossen JM; Heidt PJ
Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
[TBL] [Abstract][Full Text] [Related]
18. Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.
Cleveland MG; Lane RG; Klimpel GR
Cell Immunol; 1987 Nov; 110(1):120-30. PubMed ID: 3119228
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo interferon production in NOD mice.
Tsumura H; Komada H; Ito Y; Shimura K
Lab Anim Sci; 1989 Nov; 39(6):575-8. PubMed ID: 2512417
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells.
Brok HP; Vossen JM; Heidt PJ
Bone Marrow Transplant; 1998 Nov; 22(10):1005-10. PubMed ID: 9849699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
